KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GoodRx Holdings (GDRX) Other Operating Expenses (2019 - 2025)

Historic Other Operating Expenses for GoodRx Holdings (GDRX) over the last 7 years, with Q3 2025 value amounting to $118.4 million.

  • GoodRx Holdings' Other Operating Expenses fell 59.12% to $118.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $480.3 million, marking a year-over-year decrease of 624.88%. This contributed to the annual value of $480.4 million for FY2024, which is 601.7% down from last year.
  • Per GoodRx Holdings' latest filing, its Other Operating Expenses stood at $118.4 million for Q3 2025, which was down 59.12% from $117.9 million recorded in Q2 2025.
  • In the past 5 years, GoodRx Holdings' Other Operating Expenses ranged from a high of $152.5 million in Q4 2023 and a low of -$47.9 million during Q4 2021
  • For the 5-year period, GoodRx Holdings' Other Operating Expenses averaged around $82.7 million, with its median value being $117.9 million (2025).
  • Its Other Operating Expenses has fluctuated over the past 5 years, first plummeted by 15404.53% in 2021, then surged by 783473.63% in 2023.
  • Quarter analysis of 5 years shows GoodRx Holdings' Other Operating Expenses stood at -$47.9 million in 2021, then soared by 95.88% to -$2.0 million in 2022, then surged by 7834.74% to $152.5 million in 2023, then decreased by 17.97% to $125.1 million in 2024, then dropped by 5.38% to $118.4 million in 2025.
  • Its Other Operating Expenses was $118.4 million in Q3 2025, compared to $117.9 million in Q2 2025 and $118.8 million in Q1 2025.